Baillie Gifford & CO Alector, Inc. Transaction History

Baillie Gifford & CO

  • $131 Billion
  • Q3 2024

A detailed history of Baillie Gifford & CO transactions in Alector, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 78,835 shares of ALEC stock, worth $146,633. This represents 0.0% of its overall portfolio holdings.

Number of Shares
78,835
Previous 260,442 69.73%
Holding current value
$146,633
Previous $1.18 Million 68.87%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$4.34 - $6.58 $788,174 - $1.19 Million
-181,607 Reduced 69.73%
78,835 $368,000
Q2 2024

Jul 25, 2024
SELL
$4.19 - $6.23 $261,401 - $388,671
-62,387 Reduced 19.33%
260,442 $1.18 Million
Q1 2024

May 01, 2024
SELL
$5.69 - $8.08 $131,410 - $186,607
-23,095 Reduced 6.68%
322,829 $1.94 Million
Q4 2023

Jan 26, 2024
SELL
$3.77 - $8.39 $83,120 - $184,982
-22,048 Reduced 5.99%
345,924 $2.76 Million
Q3 2023

Nov 13, 2023
SELL
$5.2 - $8.77 $88,878 - $149,896
-17,092 Reduced 4.44%
367,972 $2.38 Million
Q2 2023

Jul 28, 2023
SELL
$5.86 - $7.93 $29,587 - $40,038
-5,049 Reduced 1.29%
385,064 $2.31 Million
Q1 2023

May 03, 2023
BUY
$5.85 - $9.84 $24,312 - $40,895
4,156 Added 1.08%
390,113 $2.41 Million
Q4 2022

Jan 24, 2023
BUY
$6.88 - $9.55 $97,145 - $134,846
14,120 Added 3.8%
385,957 $3.56 Million
Q3 2022

Oct 27, 2022
BUY
$8.19 - $13.2 $142,055 - $228,954
17,345 Added 4.89%
371,837 $3.52 Million
Q2 2022

Aug 08, 2022
SELL
$7.65 - $14.24 $289,621 - $539,112
-37,859 Reduced 9.65%
354,492 $3.6 Million
Q1 2022

May 05, 2022
BUY
$13.02 - $20.78 $424,803 - $677,989
32,627 Added 9.07%
392,351 $5.59 Million
Q4 2021

Jan 20, 2022
BUY
$19.35 - $25.54 $374,848 - $494,760
19,372 Added 5.69%
359,724 $7.43 Million
Q3 2021

Oct 19, 2021
BUY
$21.65 - $39.49 $855,694 - $1.56 Million
39,524 Added 13.14%
340,352 $7.77 Million
Q2 2021

Aug 02, 2021
BUY
$15.5 - $22.48 $598,532 - $868,065
38,615 Added 14.73%
300,828 $6.27 Million
Q1 2021

May 06, 2021
BUY
$14.84 - $22.23 $2.07 Million - $3.11 Million
139,807 Added 114.22%
262,213 $5.28 Million
Q4 2020

Feb 10, 2021
BUY
$9.4 - $16.7 $550,351 - $977,751
58,548 Added 91.68%
122,406 $1.85 Million
Q3 2020

Nov 12, 2020
BUY
$10.54 - $24.96 $634,423 - $1.5 Million
60,192 Added 1641.9%
63,858 $673,000
Q2 2020

Aug 12, 2020
BUY
$21.87 - $33.11 $34,860 - $52,777
1,594 Added 76.93%
3,666 $90,000
Q3 2019

Nov 07, 2019
SELL
$14.42 - $22.2 $1,629 - $2,508
-113 Reduced 5.17%
2,072 $30,000
Q1 2019

May 01, 2019
BUY
$15.97 - $22.5 $34,894 - $49,162
2,185 New
2,185 $0

Others Institutions Holding ALEC

# of Institutions
168
Shares Held
57.8M
Call Options Held
146K
Put Options Held
90.8K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $154M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email